|
Fabry Disease - Pipeline Review, H1 2019 |
Mar 29 2019 |
104 |
Global |
$2,000.00 |
|
|
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2019 |
Mar 29 2019 |
196 |
Global |
$2,000.00 |
|
|
Duchenne Muscular Dystrophy - Pipeline Review, H1 2019 |
Mar 29 2019 |
329 |
Global |
$2,000.00 |
|
|
Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2019 |
Mar 29 2019 |
62 |
Global |
$3,500.00 |
|
|
Rectal Cancer - Pipeline Review, H1 2019 |
Mar 29 2019 |
123 |
Global |
$2,000.00 |
|
|
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019 |
Mar 29 2019 |
150 |
Global |
$2,000.00 |
|
|
Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H1 2019 |
Mar 29 2019 |
72 |
Global |
$3,500.00 |
|
|
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2019 |
Mar 29 2019 |
777 |
Global |
$2,000.00 |
|
|
Periodontitis - Pipeline Review, H1 2019 |
Mar 29 2019 |
44 |
Global |
$2,000.00 |
|
|
P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H1 2019 |
Mar 29 2019 |
62 |
Global |
$3,500.00 |
|
|
Meniere Disease - Pipeline Review, H1 2019 |
Mar 29 2019 |
45 |
Global |
$2,000.00 |
|
|
Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019 |
Mar 29 2019 |
82 |
Global |
$3,500.00 |
|
|
Burns - Pipeline Review, H1 2019 |
Mar 29 2019 |
93 |
Global |
$2,000.00 |
|
|
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndrome) - Pipeline Review, H1 2019 |
Mar 29 2019 |
135 |
Global |
$2,000.00 |
|
|
Ocular Hypertension - Pipeline Review, H1 2019 |
Mar 29 2019 |
131 |
Global |
$2,000.00 |
|
|
Becker Muscular Dystrophy - Pipeline Review, H1 2019 |
Mar 29 2019 |
61 |
Global |
$2,000.00 |
|
|
Cat Allergy - Pipeline Review, H1 2019 |
Mar 29 2019 |
29 |
Global |
$2,000.00 |
|
|
Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2019 |
Mar 29 2019 |
89 |
Global |
$2,000.00 |
|
|
Cough - Pipeline Review, H1 2019 |
Mar 29 2019 |
95 |
Global |
$2,000.00 |
|
|
Familial Adenomatous Polyposis - Pipeline Review, H1 2019 |
Mar 29 2019 |
61 |
Global |
$2,000.00 |
|
|
Leiomyosarcoma - Pipeline Review, H1 2019 |
Mar 29 2019 |
461 |
Global |
$2,000.00 |
|
|
Primary Immune Deficiency (PID) - Pipeline Review, H1 2019 |
Mar 29 2019 |
104 |
Global |
$2,000.00 |
|
|
Tumor Necrosis Factor Receptor Superfamily Member 1A (Tumor Necrosis Factor Receptor 1 or Tumor Necrosis Factor Receptor Type I or p55 or p60 or CD120a or TNFRSF1A) - Pipeline Review, H1 2019 |
Mar 29 2019 |
61 |
Global |
$3,500.00 |
|
|
Anal Cancer - Pipeline Review, H1 2019 |
Mar 29 2019 |
390 |
Global |
$2,000.00 |
|
|
Toll Like Receptor 4 (hToll or CD284 or TLR4) - Pipeline Review, H1 2019 |
Mar 29 2019 |
118 |
Global |
$3,500.00 |
|
|
Chemotherapy Induced Anemia - Pipeline Review, H1 2019 |
Mar 29 2019 |
44 |
Global |
$2,000.00 |
|
|
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2019 |
Mar 29 2019 |
49 |
Global |
$3,500.00 |
|
|
Nasal Polyps (Nasal Polyposis) - Pipeline Review, H1 2019 |
Mar 29 2019 |
96 |
Global |
$2,000.00 |
|
|
Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H1 2019 |
Mar 29 2019 |
55 |
Global |
$3,500.00 |
|
|
Scar - Pipeline Review, H1 2019 |
Mar 29 2019 |
82 |
Global |
$2,000.00 |
|
